Prakiraan rega marang bathi: RXi Pharmaceuticals (PHIO)
Phio Pharmaceuticals specializes narrowly in immuno-oncology, mitigating pipeline risks through strategic partnerships. Success is based on the INTASYL system, which enables RNA interference to penetrate cells without the use of lipids. Stability is ensured by strong intellectual property within cancer therapy. The trend of the company's expected price-to-earnings multiple clearly demonstrates a market revaluation, while 0.00 captures the current state of the parameter.
Rincian analitis perusahaan Phio Pharmaceuticals
- nilai saham lan prakiraan konsensus rega:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- indikator beban utang lan likuiditas:
Total Utang marang Modal Phio Pharmaceuticals|PHIO - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Phio Pharmaceuticals|PHIO - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku Phio Pharmaceuticals Corp|PHIO - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan Phio Pharmaceuticals|Rasio cepet phiopharma.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
PHIO - Penghasilan resik|Proyeksi bathi mangsa ngarep Phio Pharmaceuticals|PHIO - Kapitalisasi marang bathi|Prakiraan rega marang bathi Phio Pharmaceuticals|PHIO - Pangali PEG|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Phio Pharmaceuticals Corp|PHIO - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi resik saben saham (EPS TTM) Phio Pharmaceuticals|PHIO - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi EPS kuartalan phiopharma.com|PHIO - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Phio Pharmaceuticals
- indikator dodolan lan pendapatan:
Pambiji fundamental:PHIO Phio Pharmaceuticals Corp.
For Phio Pharmaceuticals (PHIO), which is currently in the R&D stage without stable revenues, the forward P/E ratio serves as an indicator of market speculation regarding the success of clinical trials. This ratio correlates current market capitalization with projected net income, demonstrating the gap between the share price and fundamental value, which, in the absence of profit, signals high risks if growth targets are not met.
Pesaing Phio Pharmaceuticals
Rega marang bathi mangsa ngarep Tempus Labs (TEM)|QGEN - Rasio prakiraan rega marang bathi|Ionis Pharma - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi RGEN|RNA - Rega marang bathi mangsa ngarep|Rasio rega marang bathi sing dikarepake CRSP|WGS: Pangali Forward P/E|Ultragenyx Pharmaceutical Inc. - Pangali mangsa ngarep rega marang bathi|BEAM (Beam Therapeutics Corp) - Pangali Forward P/E|Pangali Forward P/E Sarepta Corp|Rega marang bathi mangsa ngarep Twist Bioscience (TWST)|TXG (10xgenomics.com) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Intellia Therapeutics, Inc. NTLA|STOK - Prakiraan rega marang bathi|BioLife Corp - Pangali Forward P/E|WVE - Pangali Forward P/E|MAZE: Pangali Forward P/E|Prakiraan rega marang bathi sionnatx.com|PRME (Prime Medicine) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Taysha Gene Therapies Inc TSHA|Prakiraan rega marang bathi QURE (uniQure Corp)|Pangali Forward P/E MeiraGTx Corp (MGTX)|REGENXBIO Inc. - Prakiraan rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep SLDB (solidbio.com)|Ocugen - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi Pacific Biosciences of California, Inc. PACB|BNTC: Pangali Forward P/E|Prakiraan rega marang bathi Design Corp|RCKT (Rocket Pharmaceuticals) - Pangali Forward P/E|Pangali Forward P/E 4dmoleculartherapeutics.com|Rega marang bathi mangsa ngarep Lexeo Therapeutics (LXEO)|Rega marang bathi mangsa ngarep KRRO (korrobio.com)|Rega marang bathi mangsa ngarep Editas EDIT|Kapitalisasi marang proyeksi bathi Silence Therapeutics Corp (SLN)|PRQR - Rega marang bathi mangsa ngarep|Rasio rega marang bathi sing dikarepake CDXS|SGMO: Pangali Forward P/E|Nautilus Bio - Pangali mangsa ngarep rega marang bathi|MGX (Metagenomi, Inc) - Pangali Forward P/E|Precision BioSciences Inc. (DTIL) - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Generation Bio Co. (GBIO)|BOLD - Rasio prakiraan rega marang bathi|Pangali Forward P/E XCUR (Exicure)|IMNN: Rasio rega marang bathi mangsa ngarep|MBIO - Rega marang bathi mangsa ngarep|RNAZ (TransCode Therapeutics) - Rasio rega marang bathi mangsa ngarep|BNGO: Pangali Forward P/E|adnas.com (APDN) - Pangali Forward P/E|Rega marang bathi mangsa ngarep bluebird bio|ImmunoPrecise - Rasio rega marang bathi sing dikarepake|Pangali Forward P/E OMGA|OMIC (Singular Genomics Corp) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E RGLS (Regulus Therapeutics)|Kapitalisasi marang proyeksi bathi syros.com (SYRS)|TBIO - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi TRACON Pharmaceuticals Inc.|UBX (Unity Bio) - Prakiraan rega marang bathi
